Enantioselectivity of Haloalkane Dehalogenases and its Modulation by Surface Loop Engineering
作者:Zbynek Prokop、Yukari Sato、Jan Brezovsky、Tomas Mozga、Radka Chaloupkova、Tana Koudelakova、Petr Jerabek、Veronika Stepankova、Ryo Natsume、Jan G. E. van Leeuwen、Dick B. Janssen、Jan Florian、Yuji Nagata、Toshiya Senda、Jiri Damborsky
DOI:10.1002/anie.201001753
日期:2010.8.16
In the loop: Engineering of the surfaceloop in haloalkanedehalogenases affects their enantiodiscrimination behavior. The temperature dependence of the enantioselectivity (lnE versus 1/T) of β‐bromoalkanes by haloalkanedehalogenases is reversed (red data points) by deletion of the surfaceloop; the selectivity switches back when an additional single‐point mutation is made. This behavior is not observed
Substituted anilinic piperidines as MCH selective antagonists
申请人:Marzabadi R. Mohammad
公开号:US20070043080A1
公开(公告)日:2007-02-22
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.